353 related articles for article (PubMed ID: 29114070)
21. Alternative splicing of HSPA12A pre-RNA by SRSF11 contributes to metastasis potential of colorectal cancer.
Pan YJ; Huo FC; Kang MJ; Liu BW; Wu MD; Pei DS
Clin Transl Med; 2022 Nov; 12(11):e1113. PubMed ID: 36394206
[TBL] [Abstract][Full Text] [Related]
22. SRSF6 is upregulated in asthmatic horses and involved in the MYH11 SMB expression.
Issouf M; Vargas A; Boivin R; Lavoie JP
Physiol Rep; 2018 Oct; 6(20):e13896. PubMed ID: 30350466
[TBL] [Abstract][Full Text] [Related]
23. Silencing Srsf6 does not modulate incomplete splicing of the huntingtin gene in Huntington's disease models.
Mason MA; Gomez-Paredes C; Sathasivam K; Neueder A; Papadopoulou AS; Bates GP
Sci Rep; 2020 Aug; 10(1):14057. PubMed ID: 32820193
[TBL] [Abstract][Full Text] [Related]
24. DRAK2 aggravates nonalcoholic fatty liver disease progression through SRSF6-associated RNA alternative splicing.
Li Y; Xu J; Lu Y; Bian H; Yang L; Wu H; Zhang X; Zhang B; Xiong M; Chang Y; Tang J; Yang F; Zhao L; Li J; Gao X; Xia M; Tan M; Li J
Cell Metab; 2021 Oct; 33(10):2004-2020.e9. PubMed ID: 34614409
[TBL] [Abstract][Full Text] [Related]
25. Long-read sequencing reveals the landscape of aberrant alternative splicing and novel therapeutic target in colorectal cancer.
Sun Q; Han Y; He J; Wang J; Ma X; Ning Q; Zhao Q; Jin Q; Yang L; Li S; Li Y; Zhi Q; Zheng J; Dong D
Genome Med; 2023 Sep; 15(1):76. PubMed ID: 37735421
[TBL] [Abstract][Full Text] [Related]
26. SRSF6 Regulates the Alternative Splicing of the Apoptotic Fas Gene by Targeting a Novel RNA Sequence.
Choi N; Jang HN; Oh J; Ha J; Park H; Zheng X; Lee S; Shen H
Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454897
[TBL] [Abstract][Full Text] [Related]
27. Splicing factor SRSF6 mediates pleural fibrosis.
Liang LM; Xiong L; Cheng PP; Chen SJ; Feng X; Zhou YY; Niu Q; Wang M; Chen Q; Song LJ; Yu F; He XL; Xiang F; Wang X; Ye H; Ma WL
JCI Insight; 2021 May; 6(10):. PubMed ID: 33905374
[TBL] [Abstract][Full Text] [Related]
28. LIM kinase 1 interacts with myosin-9 and alpha-actinin-4 and promotes colorectal cancer progression.
Liao Q; Li R; Zhou R; Pan Z; Xu L; Ding Y; Zhao L
Br J Cancer; 2017 Aug; 117(4):563-571. PubMed ID: 28664914
[TBL] [Abstract][Full Text] [Related]
29. The SRSF3-MBNL1-Acin1 circuit constitutes an emerging axis to lessen DNA fragmentation in colorectal cancer via an alternative splicing mechanism.
Chen YS; Liu CW; Lin YC; Tsai CY; Yang CH; Lin JC
Neoplasia; 2020 Dec; 22(12):702-713. PubMed ID: 33142236
[TBL] [Abstract][Full Text] [Related]
30. Long non-coding RNA TP73-AS1 sponges miR-194 to promote colorectal cancer cell proliferation, migration and invasion via up-regulating TGFα.
Cai Y; Yan P; Zhang G; Yang W; Wang H; Cheng X
Cancer Biomark; 2018; 23(1):145-156. PubMed ID: 30010111
[TBL] [Abstract][Full Text] [Related]
31. Identification of novel alternative splicing isoform biomarkers and their association with overall survival in colorectal cancer.
Lian H; Wang A; Shen Y; Wang Q; Zhou Z; Zhang R; Li K; Liu C; Jia H
BMC Gastroenterol; 2020 Jun; 20(1):171. PubMed ID: 32503434
[TBL] [Abstract][Full Text] [Related]
32. miR-193a-5p promotes pancreatic cancer cell metastasis through SRSF6-mediated alternative splicing of OGDHL and ECM1.
Li M; Wu P; Yang Z; Deng S; Ni L; Zhang Y; Jin L; Pan Y
Am J Cancer Res; 2020; 10(1):38-59. PubMed ID: 32064152
[TBL] [Abstract][Full Text] [Related]
33. Analysis of Colorectal Cancer-Associated Alternative Splicing Based on Transcriptome.
Zhang J; Deng Y; Zuo Y; Wang J; Zhao Y
DNA Cell Biol; 2020 Jan; 39(1):16-24. PubMed ID: 31808724
[TBL] [Abstract][Full Text] [Related]
34. HNRNPLL, a newly identified colorectal cancer metastasis suppressor, modulates alternative splicing of
Sakuma K; Sasaki E; Kimura K; Komori K; Shimizu Y; Yatabe Y; Aoki M
Gut; 2018 Jun; 67(6):1103-1111. PubMed ID: 28360095
[TBL] [Abstract][Full Text] [Related]
35. Profiles of alternative splicing in colorectal cancer and their clinical significance: A study based on large-scale sequencing data.
Xiong Y; Deng Y; Wang K; Zhou H; Zheng X; Si L; Fu Z
EBioMedicine; 2018 Oct; 36():183-195. PubMed ID: 30243491
[TBL] [Abstract][Full Text] [Related]
36. Long noncoding RNA GAPLINC promotes invasion in colorectal cancer by targeting SNAI2 through binding with PSF and NONO.
Yang P; Chen T; Xu Z; Zhu H; Wang J; He Z
Oncotarget; 2016 Jul; 7(27):42183-42194. PubMed ID: 27259250
[TBL] [Abstract][Full Text] [Related]
37. Increased expression of Solute carrier family 12 member 5 via gene amplification contributes to tumour progression and metastasis and associates with poor survival in colorectal cancer.
Xu L; Li X; Cai M; Chen J; Li X; Wu WK; Kang W; Tong J; To KF; Guan XY; Sung JJ; Chan FK; Yu J
Gut; 2016 Apr; 65(4):635-46. PubMed ID: 25947013
[TBL] [Abstract][Full Text] [Related]
38. The impact of RNA binding motif protein 4-regulated splicing cascade on the progression and metabolism of colorectal cancer cells.
Liang YC; Lin WC; Lin YJ; Lin JC
Oncotarget; 2015 Nov; 6(35):38046-60. PubMed ID: 26506517
[TBL] [Abstract][Full Text] [Related]
39. Comparative analysis of the DYRK1A-SRSF6-TNNT2 pathway in myocardial tissue from individuals with and without Down syndrome.
Quiñones-Lombraña A; Blanco JG
Exp Mol Pathol; 2019 Oct; 110():104268. PubMed ID: 31201803
[TBL] [Abstract][Full Text] [Related]
40. Histone demethylase PHF8 accelerates the progression of colorectal cancer and can be regulated by miR-488 in vitro.
Lv Y; Shi Y; Han Q; Dai G
Mol Med Rep; 2017 Oct; 16(4):4437-4444. PubMed ID: 28765946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
